髓瘤 的英文怎麼說
中文拼音 [suǐliú]-
In addition, the ability of mscs to make asparagine might be decreased by cancer drugs already known to disrupt msc activity
另外那些已經知道的破壞骨髓間充質幹細胞活性的腫瘤藥物應該可以降低骨髓間充質幹細胞產生天冬酰胺的能力。The most frequent mistreating is curettage for a malignant lesion based on a misdiagnosis, such as osteomyelitis, fibrodysplacia, gct, cyst, etc
對惡性骨腫瘤給予刮除植骨.該類錯誤治療的原因多是誤診為骨髓炎、纖維結構不良、骨巨細胞瘤或囊腫等。The lesson to be learned from the present case is that a transient plasma cell dyscrasia may present like multiple myeloma in the setting of heavy immunosuppression after organ transplantation
從這個病例中得到的教訓是，在器官移植后的嚴重免疫抑制狀況下，暫時性血細胞惡液質可以有類似多發性骨髓瘤樣的表現。This is a myxopapillary ependymoma, which is typically found arising in the filum terminale of the spinal cord
黏液性乳頭狀室管膜瘤，最常出現在脊髓終絲。Application of ultrasonic emulsification and aspirating in treatment of tethered cord syndrome with lipoma
術中應用超聲乳化治療脂肪瘤型脊髓拴系綜合征Fifty patients with primary spinal tumors operated in mackay memorial hospital between 1985 and 1995 were reviewed retrospectively
摘要本文系回顧並追蹤過去10年間在馬偕紀念醫院住院及接受手街之50位椎管內脊髓腫瘤之病例。Sixteen tumors were located in the midbrain, three in the pons, and one in the medulla oblongata
其中16人腫瘤定位在中腦， 3人在腦橋， 1人在延髓。The changes of bone mineral density in patients with multiple myeloma
多發性骨髓瘤患者骨密度的改變The most frequent cancer diagnosis was multiple myeloma ( in 63 % )
這些病人中最常見的疾病是多發性骨髓瘤（ 63 % ） 。Clinical and prognosis analysis of multiple myeloma patients with renal dysfunction
多發性骨髓瘤腎功能不全患者臨床與預後分析Clinical characteristics and relational factors analysis of multiple myeloma with renal involvement
多發性骨髓瘤腎損害臨床特徵及有關因素分析Anticancer actiity of this agent has been reported in arious malignant disorders, including multiple myeloma and myelodysplastic syndrome
它對多種腫瘤具有抗腫瘤活性，其中包括骨髓瘤和骨髓增生異常綜合征。Lab - grown cancer cells treated with sildenafil showed similar results, as did tissue samples taken from 14 head and neck cancer and multiple myeloma patients
昔多芬在實驗室培養的腫瘤細胞上可見到同樣效果，同時，在14個頭頸部腫瘤和多發性骨髓瘤患者的組織樣品中也可以出現同樣的效果。" on the basis of our experience, we suggest that the standard of care for patients with smoldering multiple myeloma should be close follow - up eery few months, " the researchers conclude
在我們的研究基礎上，我們建議無癥狀多發性骨髓瘤患者的監護標準應每隔幾個月進行一次嚴密隨訪。研究者總結說。In most cases of chronic urticaria, an underlying trigger is not found. hodgkin ' s disease may be accompanied by urticaria. cold urticaria with cryoglobulinemia is seen in multiple myeloma
在大多數慢性蕁麻疹患者，找不到觸發原因。霍傑金氏病可伴有蕁麻疹；冷球蛋白血癥引起的蕁麻疹見于多發性骨髓瘤。Study on ft - raman spectroscopy of puc18 dna
骨髓瘤細胞的抑制作用研究This article reviews the latest progress of nucleoside analogues on the treatment of multiple myeloma in recent years and introduces the mechanism of action, preclinical study and clinical application of fludarabine and gemcitabine in treating multiple myeloma
綜述了近年來核苷類似物治療多發性骨髓瘤的最新研究進展，介紹核苷類似物氟達拉濱和吉西他濱治療多發性骨髓瘤的作用機制、基礎研究和臨床應用。As a proteasome inhibitor, bortezomib has shown inhibition on cell proliferation, inducing cell apoptosis, inhibition of cell adhension and inhibition of tumor angiogenesis for multiple myeloma cells
摘要硼替佐米作為一種蛋白酶抑制劑，對多發性骨髓瘤細胞表現出抑制細胞生長、誘導腫瘤細胞凋亡、抑制細胞粘附、抑制腫瘤血管生成等作用，同時對血液系統其他惡性腫瘤具有顯著的作用。New york ( reuters health ) jun 20 - the proportion of plasma cells in bone marrow and the serum monoclonal protein leel at diagnosis influence the risk that smoldering ( asymptomatic ) multiple myeloma will progress to symptomatic disease, new research suggests
紐約路透通訊社健康欄6月20日訊：最新研究發現，骨髓血漿細胞和血清單克隆蛋白水平的比例會影響無癥狀性多發性骨髓瘤發展為有癥狀性骨髓瘤的風險。Methods : the balb / c mouse is immunized with gene recombinant antigen p24 for four times in 2 months. the spleen cells of immunized mouse is hybridized with sp2 / 0 by peg, and the positive cell clones secreting the antibody to antigen p24 are detected by indirect elisa. through three clonings less diversed anti - p24 hybridoma cells are gained
方法：基因工程p24抗原免疫小鼠4次，歷時2個月，取脾細胞與骨髓瘤細胞株sp2 0 ，用peg融合， hat選擇培養和間接elisa篩選分泌抗p24抗體陽性的雜交瘤細胞，三次克隆化后得穩定分泌抗p24抗體的雜交瘤細胞株。分享友人